Felis-Giemza, Anna.
Anna Felis-Giemza
VIAF ID: 317140315 (Personal)
Permalink: http://viaf.org/viaf/317140315
Preferred Forms
- 100 0 _ ‡a Anna Felis-Giemza
-
-
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases | |
Antimalarials - are they effective and safe in rheumatic diseases? | |
Association study between immune-related miRNAs and mixed connective tissue disease | |
Capillaroscopy - a role in modern rheumatology | |
Choroby reumatyczne | |
Discrepancies in assessment of patients with rheumatoid arthritis and secondary Sjögren's syndrome by DAS28-ESR and DAS28-CRP. | |
Doświadczenia w zamianie leków biologicznych w obszarze reumatologii | |
Genetic polymorphisms of Foxp3 in patients with rheumatoid arthritis | |
Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome | |
Interferons (IFN-A/-B/-G) Genetic Variants in Patients with Mixed Connective Tissue Disease (MCTD) | |
Interleukin 6 blockage-induced neutropenia in a patient with rheumatoid arthritis and resolved hepatitis B | |
The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients | |
Measurement of anti-drug antibodies to biologic drugs | |
Mieszana choroba tkanki łącznej = Mixed connective tissue disease | |
New era of treatment with biologics in rheumatology - is it time to shift paradigms in treatment with biologics? | |
Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar | |
Osteoporozy wtórne | |
Poprawa jakości i dostępności do leczenia biologicznego w Polsce : rekomendacje : raport ekspercki | |
Przygotowanie pacjenta reumatologicznego do leczenia biologicznego : na co należy zwrócić uwagę = Initiation of the biologic treatment in rheumatologic patient : what should be consider before? | |
Radionuclide synovectomy - essentials for rheumatologists | |
The Role of MECP2 and CCR5 Polymorphisms on the Development and Course of Systemic Lupus Erythematosus | |
Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study | |
Schnitzler Syndrome in a 27-Year-Old Man: Diagnostic and Therapeutic Dilemma in Adult Auto-Inflammatory Syndromes A Case Report and Literature Review | |
Treatment of rheumatic diseases and hepatitis B virus coinfection | |
Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD |